Imperial College London
Alternate

ProfessorMariaBelvisi

Faculty of Medicine, National Heart & Lung Institute

Professor of Respiratory Pharmacology
 
 
 
//

Contact

 

+44 (0)20 7594 7828m.belvisi

 
 
//

Location

 

107Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Sadiq:2022:10.1111/bcp.14956,
author = {Sadiq, MW and Asimus, S and Belvisi, MG and Brailsford, W and Fransson, R and Fuhr, R and Hagberg, A and Hashemi, M and Jensen, TJ and Jonsson, J and Keen, C and Koernicke, T and Kristensson, C and Maenpaa, J and Necander, S and Nemes, S and Betts, J},
doi = {10.1111/bcp.14956},
journal = {BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
pages = {260--270},
title = {Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease},
url = {http://dx.doi.org/10.1111/bcp.14956},
volume = {88},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Sadiq,MW
AU  - Asimus,S
AU  - Belvisi,MG
AU  - Brailsford,W
AU  - Fransson,R
AU  - Fuhr,R
AU  - Hagberg,A
AU  - Hashemi,M
AU  - Jensen,TJ
AU  - Jonsson,J
AU  - Keen,C
AU  - Koernicke,T
AU  - Kristensson,C
AU  - Maenpaa,J
AU  - Necander,S
AU  - Nemes,S
AU  - Betts,J
DO  - 10.1111/bcp.14956
EP  - 270
PY  - 2022///
SN  - 0306-5251
SP  - 260
TI  - Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease
T2  - BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
UR  - http://dx.doi.org/10.1111/bcp.14956
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000682867500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 88
ER  -
Download